部委领导、人大代表表态了:这些药还得涨价!

2018-03-05 遥望 赛柏蓝

中药美国爆红,部委领导也关注!此外,多位人大代表、政协委员关于中医药质量问题、提价问题、产品标准问题等也表达了自己的观点。

中药美国爆红,部委领导也关注!此外,多位人大代表、政协委员关于中医药质量问题、提价问题、产品标准问题等也表达了自己的观点。

王国强局长:中医药走出去还有很长的路

流感肆虐下,价格炒至450元一瓶的枇杷膏在美国卖到脱销,成为“世界网红”。

3月3日下午,全国政协十三届一次会议开幕会结束后,国家中医药管理局局长王国强在“部长通道”就这一现象回答了记者提问。

“目前,中医药已传播到世界183个国家和地区,我国政府同外国政府、国际组织、地区主管机构签署了86个中医药合作协议,推动建立17个海外中医药中心。然而由于中西方文化差异等原因,中医药国际准入还面临一些障碍,中医药走出去还有很长的路要走。”

步长制药总裁赵超:加大对中药小劣企业的监管和淘汰

除枇杷膏外,马应龙痔疮膏、拔罐、枸杞、艾灸贴、风油精、云南白药等“中国特产”早就在国外流行了起来 。

关于中药,除从国内火到国外外,关于其药材种植、中药颗粒放开、频繁提价、部分产品质量标准不明等问题也一直是热议的焦点。

3月4日,中国医药企业管理协会等中国医药行业25家协(学)会主办的2018第十届“声音?责任”医药界全国人大代表政协委员座谈会在北京召开。

关于中药国际化,陕西步长制药总裁赵超提出中药国际化依托于中药大平台和中药大品种。

此外,赵超呼吁政府加大对龙头中药企业的扶持,加大对小劣企业的监管和淘汰。

康恩贝胡季强:消费升级、药材提质,需适应中药价格上涨

继东阿阿胶、马应龙、云南白药公告产品涨价后,近日佛慈制药近日发布公告称,自今年3月1日起,将对浓缩丸、大蜜丸、水丸、口服液、胶剂、颗粒剂、片剂等多种剂型的100多个产品进行全线提价,出厂价平均上调17.6%,零售价也将相应进行调整。

可以说中药提价已经成为一种常态,甚至部分中药已经脱离普通消费者的消费水平。

对此,浙江康恩贝制药股份有限公司董事长胡季强就拿东阿阿胶举例说到,不少中药,完全放弃医保,不提价,做不出市场体量。

此外,胡季强在现场接受媒体采访时也表示,随着消费升级,优质中药涨价也是必然。

关于中药提价,其实也不难理解。中药材种植“散户”淘汰,收紧中药材产量。而中药运用范围越来越广,这就导致供需缺口在局部变大。

有行业观察人士表示,“几乎所有的药企提到涨价原因时都会无奈表示原料成本上涨是主因。”

附:部分政协委员关于中医药的精彩观点

民革黑龙江省委员会主委、黑龙江省人大常委会副主任 谷振春委员:康养产业在龙江大地上正处于方兴未艾的状态,中医康养,比如五大连池的温泉药疗,林甸温泉,很多地方都在开发这样一些项目,把传统的项目进行拓展延伸,地方政府的有关部门都在进行有关探索,相信未来龙江的旅游康养项目,中医的康养项目会有一个新的变化。

北京市卫生计生委党委书记 方来英委员:中医药在基层有很大的作用,一是中医疗法确实简、便、验、廉,特别适合在基层推广使用;二是中医更具备全科服务的特点,这和我们市民的需要是紧密相关的,发展中医药是我们必须关注的,而且中医也是我们向世界传播中国文化的重要方面,我们应该中医介绍给全世界。

360公司创始人、董事长兼首席执行官、九三学社中央委员会委员 周鸿祎委员:我觉得中医药是中华传统文化的宝藏,我们都支持中医药的研究和发展。

北京人民艺术剧院演员 冯远征委员:中医与中国人血脉分割不开,中医符合中国人的身体需要,祖宗所做的探索是有一定科学性的。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1914081, encodeId=82b51914081dd, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Mon Aug 20 08:33:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294894, encodeId=bc56294894a3, content=好消息.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Mar 10 15:20:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448054, encodeId=e28d14480544b, content=<a href='/topic/show?id=1f65658e68b' target=_blank style='color:#2F92EE;'>#涨价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65876, encryptionId=1f65658e68b, topicName=涨价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10805383454, createdName=tamgche, createdTime=Wed Mar 07 02:33:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293292, encodeId=1a60293292f0, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:19 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293242, encodeId=4e3929324284, content=学习了提高了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Mon Mar 05 13:11:22 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1914081, encodeId=82b51914081dd, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Mon Aug 20 08:33:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294894, encodeId=bc56294894a3, content=好消息.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Mar 10 15:20:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448054, encodeId=e28d14480544b, content=<a href='/topic/show?id=1f65658e68b' target=_blank style='color:#2F92EE;'>#涨价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65876, encryptionId=1f65658e68b, topicName=涨价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10805383454, createdName=tamgche, createdTime=Wed Mar 07 02:33:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293292, encodeId=1a60293292f0, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:19 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293242, encodeId=4e3929324284, content=学习了提高了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Mon Mar 05 13:11:22 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-10 zb1235672

    好消息.值得学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1914081, encodeId=82b51914081dd, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Mon Aug 20 08:33:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294894, encodeId=bc56294894a3, content=好消息.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Mar 10 15:20:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448054, encodeId=e28d14480544b, content=<a href='/topic/show?id=1f65658e68b' target=_blank style='color:#2F92EE;'>#涨价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65876, encryptionId=1f65658e68b, topicName=涨价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10805383454, createdName=tamgche, createdTime=Wed Mar 07 02:33:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293292, encodeId=1a60293292f0, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:19 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293242, encodeId=4e3929324284, content=学习了提高了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Mon Mar 05 13:11:22 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-07 tamgche
  4. [GetPortalCommentsPageByObjectIdResponse(id=1914081, encodeId=82b51914081dd, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Mon Aug 20 08:33:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294894, encodeId=bc56294894a3, content=好消息.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Mar 10 15:20:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448054, encodeId=e28d14480544b, content=<a href='/topic/show?id=1f65658e68b' target=_blank style='color:#2F92EE;'>#涨价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65876, encryptionId=1f65658e68b, topicName=涨价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10805383454, createdName=tamgche, createdTime=Wed Mar 07 02:33:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293292, encodeId=1a60293292f0, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:19 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293242, encodeId=4e3929324284, content=学习了提高了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Mon Mar 05 13:11:22 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-05 惠映实验室

    学习.谢谢分享.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1914081, encodeId=82b51914081dd, content=<a href='/topic/show?id=048124e61f7' target=_blank style='color:#2F92EE;'>#人大代表#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24761, encryptionId=048124e61f7, topicName=人大代表)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Mon Aug 20 08:33:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294894, encodeId=bc56294894a3, content=好消息.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Mar 10 15:20:00 CST 2018, time=2018-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448054, encodeId=e28d14480544b, content=<a href='/topic/show?id=1f65658e68b' target=_blank style='color:#2F92EE;'>#涨价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65876, encryptionId=1f65658e68b, topicName=涨价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10805383454, createdName=tamgche, createdTime=Wed Mar 07 02:33:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293292, encodeId=1a60293292f0, content=学习.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Mar 05 19:43:19 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293242, encodeId=4e3929324284, content=学习了提高了, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/21/39b6a0099eb602e8ac1f7e10d5d440a9.jpg, createdBy=dee01724555, createdName=杨利洪, createdTime=Mon Mar 05 13:11:22 CST 2018, time=2018-03-05, status=1, ipAttribution=)]
    2018-03-05 杨利洪

    学习了提高了

    0

相关资讯

这些药易混淆,工作中一定注意核对!

临床用药种类繁多,准确用药关乎病人的生命安全,因此,准确分辨药物至关重要。

读懂精神科药品不良反应

面对精神科药品说明书上描述众多的不良反应,患者和家属越看越怕,也越看越看不懂,不良反应写的太专业,即使对于非精神科的医护人员,完全理解说明书上所述的不良反应也是有一定困难的。

“热药爷爷”走红网络 药品与温度的关系没这么简单

采访专家:赵 宁(北京大学第一医院副主任药师)杜广清(北京康复医院药剂科主任药师)肖志云(中日友好医院预防保健科高级健康管理师)近日,一张“暖心”照片在网络热传。照片中,一个生病的小男孩坐在椅子上输液,站在他身后一位白发苍苍的老人怕孩子输液太冷,选择了用嘴含着输液管“加热”。据了解,这位大爷在小孙子打针的3天时间里,一直这样坚持用嘴为孩子“加热”药水。这一幕被同到江苏睢宁县桃园镇卫生院挂水的其

13药品断货,被调查

昨日(2月7日),辽宁省再发通知,13种药品将接受调查。

十一部委联合整治虚假违法广告,突出医疗、药品等重点领域

日前,工商总局、中央宣传部、中央网信办、工业和信息化部、公安部、国家卫生计生委、中国人民银行、新闻出版广电总局、食品药品监管总局、银监会、国家中医药管理局等十一部委联合下发2018年整治虚假违法广告部际联席会议工作要点,进一步明确联席会议各成员单位的部门职责,并就落实工作提出具体要求。

湖北着力打通药品供应短缺的“肠梗阻”

药品短缺问题成因复杂,涉及研发注册、生产流通、采购使用等各个环节。近日,湖北提出着力构建全省短缺药品供应保障工作会商联动机制,将重在打通信息收集、采购使用等环节“肠梗阻”,进一步加强涉药管理部门协调,建立长效运行机制,减少药品短缺发生频次。这是湖北省卫计委等十部门联合印发《关于改革完善短缺药品供应保障机制的实施方案》中提到的。按照要求,湖北全省短缺药品监测系统要不断扩大覆盖范围,逐步实现全省每个